Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Protara Therapeutics Inc (TARA)

NASDAQ
Currency in USD
Disclaimer
4.01
+0.01(+0.25%)
Closed
After Hours
4.03+0.02(+0.50%)
Fair Value
Unlock Value
Day's Range
3.954.10
52 wk Range
1.044.95
Prev. Close
4
Open
3.99
Day's Range
3.95-4.1
52 wk Range
1.04-4.95
Volume
83,563
Average Vol. (3m)
78,919
1-Year Change
19.7%
Shares Outstanding
11,433,837
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
30.60
Upside +663.09%

People Also Watch

2.370
GNSS
-1.25%
0.10
CUROQ
+5.56%
2.250
MHLD
+3.69%
1.36
APYX
-3.55%
2.230
NXTC
+15.25%
How do you feel today about TARA?
Vote to see community's results!
or
  • The FDA: Small-Cap Catalyst Or Small-Cap Killer?
    • ByWall Street Daily
  • PRTO Stock Is Worst Performer On NASDAQ
    • ByFSM News

Protara Therapeutics Inc Company Profile

Protara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying therapies for the treatment of cancer and rare diseases. The Company's pipeline includes TARA-002 and IV Choline Chloride. The Company's lead product pipeline is TARA 002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. The Company’s IV choline chloride is an investigational, intravenous (IV) phospholipid substrate replacement therapy, which is in development for patients receiving parenteral nutrition (PN) who have intestinal failure-associated liver disease (IFALD).

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.